Table 1 Demographic characteristics of the study participants as per the subgroups
Sr. no | Parameter | Treatment | T2DM patient with obesity (Mean ± SD) / n | p value | |
|---|---|---|---|---|---|
1 | Age | Biosimilar Liraglutide | 50.9 ± 8.0 | 0.85 | |
Reference Liraglutide | 51.1 ± 7.5 | ||||
2 | Gender composition | Biosimilar Liraglutide | Male | 30 | NA |
Female | 57 | ||||
Reference Liraglutide | Male | 50 | NA | ||
Female | 42 | ||||
3 | Height | Biosimilar Liraglutide | 160.1 ± 7.3 | 0.24 | |
Reference Liraglutide | 162.7 ± 8.4 | ||||
4 | Weight | Biosimilar Liraglutide | 76.4 ± 12.3 | 0.19 | |
Reference Liraglutide | 79.1 ± 15.2 | ||||
5 | BMI | Biosimilar Liraglutide | 29.8 ± 4.6 | 0.93 | |
Reference Liraglutide | 29.8 ± 4.8 | ||||